Law firm Kahn Swick & Foti launches probe into TransMedics leadership, raising governance concerns
Executive summary: Kahn Swick & Foti announced an investigation into TransMedics Group's officers and directors. The probe raises governance and potential legal risks for the medical technology company, possibly affecting investor confidence and stock price.
Who is involved: Kahn Swick & Foti (led by Charles C. Foti Jr.), TransMedics Group board and executives, and shareholders.
Likely next: The firm may release findings or recommend legal action, and TransMedics may be required to respond to regulators or disclose details.
Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti Jr., announced on August 28, 2026 that it has opened an investigation into the officers and directors of TransMedics Group, Inc. (Nasdaq: TMDX). The investigation follows a series of similar probes by the firm into other publicly traded companies and comes amid existing scrutiny from Rosen Law Firm over alleged fiduciary duty breaches. While no specific allegations have been detailed yet, the move signals potential legal exposure for the company's board and executives. Investors should watch for any forthcoming disclosures or regulatory actions that could affect the medical technology firm's standing.
Timeline
- — TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX (PR Newswire)
- — Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX (PR Newswire)
Analysis — what this means
Sectors affected
- medical technology
- organ transplant therapy
Regulatory implications
- Potential SEC enforcement under Section 10(b) of the Securities Exchange Act of 1934 for possible fiduciary duty breaches
Historical parallels
- Rosen Law Firm announced investigation of TransMedics officers/directors on August 21, 2026
Key entities
Sources
Open the full interactive case file on Beyond →